Literature DB >> 17457979

KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation in vitro.

Ping An1, Jun-Yong Zhu, Yan Yang, Peng Lv, Yi-Hao Tian, Ming-Kai Chen, He-Sheng Luo.   

Abstract

AIM: To investigate the effects of KN-93, a CaMKII selective inhibitor on cell proliferation and the expression of p53 or p21 protein in human hepatic stellate cells.
METHODS: Human hepatic stellate cells (LX-2) were incubated with various concentrations (0-50 micromol/L) of KN-93 or its inactive derivative, KN-92. Cell proliferation was measured by CCK-8 assay, and the expression of two cell cycle regulators, p53 and p21, was determined by SDS-PAGE and Western blotting.
RESULTS: KN-93 (5-50 micromol/L) decreased the proliferation of human hepatic stellate cells in a dose-dependent manner from 81.76% (81.76% +/- 2.58% vs 96.63% +/- 2.69%, P < 0.05) to 27.15% (27.15% +/- 2.86% vs 96.59% +/- 2.44%, P < 0.01) after 24 h treatment. Incubation of 10 micromol/L KN-93 induced the cell growth reduction in a time-dependent manner from 78.27% at 8 h to 11.48% at 48 h. However, KN-92, an inactive derivative of KN-93, did not inhibit cell proliferation effectively. Moreover, analysis of cell cycle regulator expression revealed that KN-93 rather than KN-92 reduced the expression of p53 and p21.
CONCLUSION: KN-93 has potent inhibitory effect on proliferation of LX-2 cells by modulating the expression of two special cell cycle regulators, p53 and p21.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457979      PMCID: PMC4146932          DOI: 10.3748/wjg.v13.i9.1445

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer.

Authors:  J J Maher; D M Bissell; S L Friedman; F J Roll
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 3.  Hepatic fibrosis as wound repair: a progress report.

Authors:  D M Bissell
Journal:  J Gastroenterol       Date:  1998-04       Impact factor: 7.527

Review 4.  The role of Ca2+/calmodulin-dependent protein kinases within the nucleus.

Authors:  E K Heist; H Schulman
Journal:  Cell Calcium       Date:  1998 Feb-Mar       Impact factor: 6.817

Review 5.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  G1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMK-II (the multifunctional Ca2+/CaM kinase).

Authors:  R M Tombes; S Grant; E H Westin; G Krystal
Journal:  Cell Growth Differ       Date:  1995-09

Review 7.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

Review 8.  Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.

Authors:  L S Cox; D P Lane
Journal:  Bioessays       Date:  1995-06       Impact factor: 4.345

9.  Calmodulin-dependent protein kinase II is required for G1/S progression in HeLa cells.

Authors:  G Rasmussen; C Rasmussen
Journal:  Biochem Cell Biol       Date:  1995 Mar-Apr       Impact factor: 3.626

10.  Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua.

Authors:  S W Han; Z M Lei; C V Rao
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  6 in total

1.  CaMKII plays a part in the chondrogenesis of bone marrow-derived mesenchymal stem cells.

Authors:  Feng Qu; Zhikun Zhao; Bangtuo Yuan; Wei Qi; Chunbao Li; Xuezhen Shen; Chang Liu; Hongliang Li; Gang Zhao; Jiangtao Wang; Qi Guo; Yujie Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Ca²⁺/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferation.

Authors:  An Ping; Tian Yihao; Dai Jingxing; Chen Minkai; Luo Hesheng
Journal:  Dig Dis Sci       Date:  2012-01-04       Impact factor: 3.199

3.  Sirolimus treatment induces dose-dependent involution of the thymus with elevated cellular respiration in BALB/c mice.

Authors:  Saeeda Almarzooqi; Charu Sharma; Dhanya Saraswathiamma; Ahmed R Alsuwaidi; Noura Hadid; Abdul-Kader Souid; Alia Albawardi
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression.

Authors:  Elwy M Soliman; Michele Angela Rodrigues; Dawidson Assis Gomes; Nina Sheung; Jin Yu; Maria Jimina Amaya; Michael H Nathanson; Jonathan A Dranoff
Journal:  Cell Calcium       Date:  2009-01-07       Impact factor: 6.817

Review 5.  Regulation of CaMKII in vivo: the importance of targeting and the intracellular microenvironment.

Authors:  Kathryn A Skelding; John A P Rostas
Journal:  Neurochem Res       Date:  2009-05-05       Impact factor: 3.996

6.  Ca2+/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways.

Authors:  Wei Chen; Ping An; Xiao-Jing Quan; Jun Zhang; Zhong-Yin Zhou; Li-Ping Zou; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.